In a long-acting dose regimen, an investigational antibodies treatment is a potent antiviral that can function as a component of a complete antiretroviral regimen.
Babafemi Taiwo, MBBS
Advertisement
Taiwo, MBBS, is head of Early Development at ViiV Healthcare.
Articles by Babafemi Taiwo, MBBS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Phase 3 Trial Confirms Superior Efficacy of Oral Pritelivir for Refractory HSV in Immunocompromised Patients
2
Invivyd Announces FDA Clearance of IND Application for VYD2311 and Advancement of REVOLUTION Clinical Program
3
Developing the Next Generation of Rifamycins for Non-TB Mycobacteria in a Postantibiotic Era
4
